CeGaT GmbH

CeGaT GmbH

Decoding of genetic information and medical interpretation of the data

Changes in genetic material can cause serious disease. At CeGaT, our top priority is to identify these disease-causing genetic mutations in patients. To identify these changes, CeGaT offers sequencing services and medical evaluation of data to patients and their families. In addition to the confirmation of a suspected diagnosis, the results may support the use of therapeutic interventions which influence the course of disease.

CeGaT’ s aim is to offer its customers a one-stop service. Therefore all steps are performed by specialists in-house. These include DNA isolation, enrichment and preparation of samples, sequencing, data analysis, and generation of a medical report by a team of experts.

The diagnostics we offer include Panel Diagnostics, Tumor Diagnostics, Exome Diagnostics, Single Gene Testing, and Pharmacogenetics. The Diagnostic Panels use state-of-the-art next-generation sequencing technologies to analyze all genes associated with the relevant disease in parallel. This service is offered for a large number of different disease types and is both more cost efficient and effective than traditional methods.

CeGaT GmbH was founded in 2009 by Dr. Dr. Saskia Biskup and Dr. Dirk Biskup, headquartered in Tübingen. For their ideas and concepts, CeGaT has been awarded two of the most important German economic awards; the Deutscher Gründerpreis in 2011, and Entrepreneur of the Year in 2013.

Category

Biotechnology

Activity Biotechnology, Diagnostic, Genetics, Oncology, Sequencing

Management

Dr. Dirk Biskup

Year of foundation

2009

Employees

150

Academic board

Prof. Dr. Stephan C. Bischoff
Prof. Dr. Peter Freisinger
Prof. Dr. Thomas Gasser
Prof. Dr. Daniel Huson
Prof. Dr. Sven Perner
Prof. Dr. Bernd Wissinger

Certificates

CeGaT is accredited by DAkkS according to DIN EN ISO 15189:2014 and by the College of American Pathologists (CAP).

News

01.10.2020

CeGaT Tests for Active Corona Infections

Since October 1, anyone who would like to (or has to) be tested for active corona infections can come to CeGaT’s premises without prior appointment. The result is available within…

29.09.2020

Update and Extension of the Panel for Genetic Eye Diseases

CeGaT has updated and expanded the Diagnostic Panel for Genetic Eye Diseases. As part of the regular updates, the panel was revised according to the current scientific knowledge,…

10.09.2020

Update and Extension of Tumor Diagnostics (TUM)

Diagnostics based on the analysis of tumor tissue plays an increasingly relevant role in the treatment of patients with tumor diseases. The more comprehensive the diagnostics, the…

27.05.2020

CeGaT Presents Results of Corona Antibody Tests

Tübingen, May 27, 2020: CeGaT GmbH started corona antibody testing May 11. In light of great public interest, CeGaT publishes statistics on the test results on its website. The…